04.2025
Orbit Genomics was selected for the MassChallenge 2025 U.S. Early-Stage Healthcare Program. Dede Willis, CEO and Co-founder says: “The energy at last week’s Boston kickoff went far beyond what I imagined. Grateful and excited for what’s next! Especially excited to be alongside an incredible group of companies – all tackling MASSive healthcare challenges with bold ideas and real impact.”